Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of Infection.
Ang CW, Lee BM, Jackson CJ, Wang Y, Franzblau SG, Francisco AF, Kelly JM, Bernhardt PV, Tan L, West NP, Sykes ML, Hinton AO, Bolisetti R, Avery VM, Cooper MA, Blaskovich MAT.
Ang CW, et al.
J Med Chem. 2022 Oct 13;65(19):13125-13142. doi: 10.1021/acs.jmedchem.2c00972. Epub 2022 Sep 16.
J Med Chem. 2022.
PMID: 36111399